Maydelid Trujillo-Nolasco

Nanoradiopharmaceuticals Based on Alpha Emitters: Recent Developments for Medical Applications

K. Katti, E. Morales-Ávila, B. Ocampo-García, 2021, Pharmaceutics.

Development of 177Lu-DN(C19)-CXCR4 Ligand Nanosystem for Combinatorial Therapy in Pancreatic Cancer.

Liliana Aranda-Lara, E. Morales-Ávila, B. Ocampo-García, 2021, Journal of biomedical nanotechnology.

177Lu-Bombesin-PLGA (paclitaxel): A targeted controlled-release nanomedicine for bimodal therapy of breast cancer.

E. Morales-Ávila, B. Ocampo-García, C. Santos-Cuevas, 2019, Materials science & engineering. C, Materials for biological applications.